Comparative mycobacterial genomics as a tool for drug target and antigen discovery

Cole S.T.

Source: Eur Respir J 2002; 20: 78S-86S

Journal Issue: July 2002 - Suppl. 36

Disease area: Respiratory infections

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Cole S.T.. Comparative mycobacterial genomics as a tool for drug target and antigen discovery. Eur Respir J 2002; 20: 78S-86S

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Omics and single molecule detection: the future of TB diagnostics Source: Eur Respir Mon 2012; 58: 144-153 Year: 2012
The genetics of asthma and the promise of genomics-guided drug discovery Source: Virtual Congress 2020 – Reducing the burden of asthma Year: 2020
High-throughput analysis of induced sputum from the U-BIOPRED study using novel proteomic and data mining approaches Source: Annual Congress 2013 –Origins and diagnosis of asthma Year: 2013
High-resolution quantitative proteomics applied to the discovery of biomarkers of innate immune response in tuberculosis. Source: International Congress 2018 – The immune response to tuberculosis: development of biomarkers and diagnostic tools Year: 2018
High-throughput molecular analysis in lung cancer: insights into biology and potential clinical applications Source: Eur Respir J 2009; 33: 489-506 Year: 2009
Towards new antituberculotic targets: biochemical characterisation of mycobacterial RNase E/G Source: Annual Congress 2007 - Novel therapeutic targets and disease markers in pulmonary pathology Year: 2007
Quantitative membrane proteomics reveals new functions ofCD13 in mycobacterium tuberculosis infection Source: International Congress 2015 – Biomarkers in TB: immunology and physiology Year: 2015
From genetical genomics to system genetics: application in asthma/COPD Source: ERS Research Seminar 2015 Year: 2015
Genetics, genomics and a systems approach to asthma Source: Annual Congress 2008 - “Omics” and systems biology: the promise of future disease understanding Year: 2008
Scene-setting: why do we need genomics and proteomics to understand pathology? Source: Annual Congress 2004 - PG7 - Application of genomics and proteomics to pulmonary disease Year: 2004
Antibody and host inflammatory biomarker combinations as diagnostic tools for TB disease Source: International Congress 2017 – Update on TB: latest news Year: 2017
An integrative genomics approach identifies new asthma pathways related to air pollution exposure Source: International Congress 2015 – Genetics, genomics and exposures in asthma and COPD Year: 2015
A fully molecular drug sensitivity pattern for M.tuberculosis complex: what is available today and what is in the pipeline Source: International Congress 2017 – How to manage difficult tuberculosis cases: diagnosis and treatment Year: 2017
Molecular epidemiology of tuberculosis Source: Eur Respir J 2002; 20: 54S-65S Year: 2002
Genomics-based identification of targets in pathogenic bacteria for potential therapeutic use Source: Annual Congress 2004 - Novel approaches to the treatment of pneumonia Year: 2004
Accelerating tuberculosis elimination in low-incidence settings: the role of genomics Source: Eur Respir J 2015; 46: 1840-1841 Year: 2015
Accelerating tuberculosis elimination in low-incidence settings: the role of genomics Source: Eur Respir J 2015; 46: 1841-1843 Year: 2015
Application of ’omics technologies to biomarker discovery in inflammatory lung diseases Source: Eur Respir J 2013; 42: 802-825 Year: 2013